Preliminary results of a 68 Ga-PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision-making.

Caroline RousseauMaelle Le ThiecLudovic FerrerDaniela RusuAurore RauscherBruno MaucheratMathieu FrindelPierre BaumgartnerVincent FleuryAntoine DenisAgnes MorelNicolas VarmenotEmilie DebeaupuisLoic CampionFrancoise Kraeber-Bodéré

Published in: The Prostate (2019)

Whilst our patient population presented a very low PSA level, preliminary results of the 68Ga-PSMA PET-CT study showed recurrence localization in more than half of the patients and this had a major clinical impact, as it resulted in treatment change in more than half of the patients and a significant decrease in PSA levels in a third of patients.

Keyphrases

pet ct
prostate cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
decision making
radical prostatectomy
case report
patient reported
combination therapy